MeDIP coupled with a promoter tiling array as a platform to investigate global DNA methylation patterns in AML cells

Leukemia Research

Volumn 37, Issue 1, 2013, Pages 102-111

  Yalcin, Arzu ^a   Kreutz, Clemens ^b   Pfeifer, Dietmar ^a   Abdelkarim, Mahmoud ^a   Klaus, Gregor ^a   Timmer, Jens ^b   Lübbert, Michael ^a   Hackanson, Björn ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Acute myeloid leukemia; DNA methylation; Epigenetics

Indexed keywords

CD34 ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 2B; ESTROGEN RECEPTOR; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; ESTROGEN RECEPTOR GENE; GENE; HUMAN; HUMAN CELL; HYBRIDIZATION; IMMUNOPRECIPITATION; LEUKEMIA CELL; METHYLATED DNA IMMUNOPRECIPITATION; MICROARRAY ANALYSIS; OLIG2 GENE; P15 GENE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; PROMOTER TILING ARRAY; PYROSEQUENCING; RAR BETA2 GENE;

ANTIGENS, CD34; CPG ISLANDS; DNA METHYLATION; HL-60 CELLS; HUMANS; IMMUNOPRECIPITATION; LEUKEMIA, MYELOID, ACUTE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS, GENETIC; SEQUENCE ANALYSIS, DNA;

EID: 84870889883     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2012.09.014     Document Type: Article

References (48)

1. Bernstein B.E., Meissner A., Lander E.S. The mammalian epigenome. Cell 2007, 128:669-681.
2. Vucic E.A., Wilson I.M., Campbell J.M., Lam W.L. Methylation analysis by DNA immunoprecipitation (MeDIP); microarray analysis of the physical genome. Methods in molecular biology 2009, 141-153. Humana Press, New York, USA. J.M. Walker (Ed.).
3. Baylin S.B., Esteller M., Rountree M.R., Bachman K.E., Schuebel K., Herman J.G. Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum Mol Genet 2001, 10:687-692.
4. Fraga M.F., Esteller M. Epigenetics and aging: the targets and the marks. Trends Genet 2007, 23:413-418.
5. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev 2002, 16:6-21.
6. Jaenisch R., Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 2003, 33:245-254.
7. Gonzalgo M.L., Liang G., Spruck C.H., Zingg J.-M., Rideout W.M., Jones P.A. Identification and characterization of differentially methylated regions of genomic DNA by methylation-sensitive arbitrarily primed PCR. Cancer Res 1997, 57:594-599.
8. Piotrowski A., Benetkiewicz M., Menzel U., de Ståhl T.D., Mantripragada K., Grigelionis G., et al. Microarray-based survey of CpG islands identifies concurrent hyper- and hypomethylation patterns in tissues derived from patients with breast cancer. Genes Chromosomes Cancer 2006, 45:656-667.
9. Esteller M. Epigenetic gene silencing in cancer: the DNA hypermethylome. Hum Mol Genet 2007, 16:R50-R59.
10. Feinberg A.P., Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 1983, 301:89-92.
11. Jones P.A., Baylin S.B. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002, 3:415-428.
12. Chekhun V.F., Lukyanova N.Y., Kovalchuk O., Tryndyak V.P., Pogribny I.P. Epigenetic profiling of multidrug-resistant human MCF-7 breast adenocarcinoma cells reveals novel hyper- and hypomethylated targets. Mol Cancer Ther 2007, 6:1089-1098.
13. Glasspool R.M., Teodoridis J.M., Brown R. Epigenetics as a mechanism driving polygenic clinical drug resistance. Br J Cancer 2006, 94:1087-1092.
14. Plimack E.R., Kantarjian H.M., Issa J.-P. Decitabine and its role in the treatment of hematopoietic malignancies. Leukemia Lymphoma 2007, 48:1472-1481.
15. Callinan P.A., Feinberg A.P. The emerging science of epigenomics. Hum Mol Genet 2006, 15:R95-R101.
16. Irizarry R.A., Ladd-Acosta C., Carvalho B., Wu H., Brandenburg S.A., Jeddeloh J.A., et al. Comprehensive high-throughput arrays for relative methylation (CHARM). Genome Res 2008, 18:780-790.
17. Khulan B., Thompson R.F., Ye K., Fazzari M.J., Suzuki M., Stasiek E., et al. Comparative isoschizomer profiling of cytosine methylation: the HELP assay. Genome Res 2006, 16:1046-1055.
18. Gebhard C., Schwarzfischer L., Pham T.-H., Schilling E., Klug M., Andreesen R., et al. Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia. Cancer Res 2006, 66:6118-6128.
19. Schilling E., Rehli M. Global, comparative analysis of tissue-specific promoter CpG methylation. Genomics 2007, 90:314-323.
20. Zhang X., Yazaki J., Sundaresan A., Cokus S., Chan S.W.L., Chen H., et al. Genome-wide high-resolution mapping and functional analysis of DNA methylation in arabidopsis. Cell 2006, 126:1189-1201.
21. Weber M., Hellmann I., Stadler M.B., Ramos L., Paabo S., Rebhan M., et al. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat Genet 2007, 39:457-466.
22. Weber M., Davies J.J., Wittig D., Oakeley E.J., Haase M., Lam W.L., et al. Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet 2005, 37:853-862.
23. Cross S.H., Charlton J.A., Nan X., Bird A.P. Purification of CpG islands using a methylated DNA binding column. Nat Genet 1994, 6:236-244.
24. Keshet I., Schlesinger Y., Farkash S., Rand E., Hecht M., Segal E., et al. Evidence for an instructive mechanism of de novo methylation in cancer cells. Nat Genet 2006, 38:149-153.
25. Koga Y., Pelizzola M., Cheng E., Krauthammer M., Sznol M., Ariyan S., et al. Genome-wide screen of promoter methylation identifies novel markers in melanoma. Genome Res 2009, 19:1462-1470.
26. Jia J., Pekowska A., Jaeger S., Benoukraf T., Ferrier P., Spicuglia S. Assessing the efficiency and significance of methylated DNA immunoprecipitation (MeDIP) assays in using in vitro methylated genomic DNA. BioMed Central 2010, 3:240.
27. Butcher L.M., Beck S. AutoMeDIP-seq: a high-throughput, whole genome, DNA methylation assay. Methods 2010, 52:223-231.
28. Collins S.J., Gallo R.C., Gallagher R.E. Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature 1977, 270:347-349.
29. Dalton W.T., Ahearn M.J., McCredie K.B., Freireich E.J., Stass S.A., Trujillo J.M. HL-60 cell line was derived from a patient with FAB-M2 and not FAB-M3. Blood 1988, 71:242-247.
30. Fatemi M., Pao M.M., Jeong S., Gal-Yam E.N., Egger G., Weisenberger D.J., et al. Footprinting of mammalian promoters: use of a CpG DNA methyltransferase revealing nucleosome positions at a single molecule level. Nucleic Acids Res 2005, 33:e176.
31. Downey T. Analysis of a multifactor microarray study using partek genomics solution. methods in enzymology 2006, Academic Press, San Diego, USA, pp. 256-270.
32. Sadikovic B., Andrews J., Carter D., Robinson J., Rodenhiser D.I. Genome-wide H3K9 histone acetylation profiles are altered in benzopyrene-treated MCF7 breast cancer cells. J Biol Chem 2008, 283:4051-4060.
33. Irizarry R.A., Hobbs B., Collin F., Beazer-Barclay Y.D., Antonellis K.J., Scherf U., et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4:249-264.
34. Johnson W.E., Li W., Meyer C.A., Gottardo R., Carroll J.S., Brown M., et al. Model-based analysis of tiling-arrays for ChIP-chip. Proc Natl Acad Sci 2006, 103:12457-12462.
35. Droit A., Cheung C. Gottardo R. rMAT - an R/Bioconductor package for analyzing ChIP-chip experiments. Bioinformatics 2010, 26:678-679.
36. Tost J., Gut I.G. DNA methylation analysis by pyrosequencing. Nat Protocols 2007, 2:2265-2275.
37. Fazi F., Zardo G., Gelmetti V., Travaglini L., Ciolfi A., Di Croce L., et al. Heterochromatic gene repression of the retinoic acid pathway in acute myeloid leukemia. Blood 2007, 109:4432-4440.
38. Hackanson B., Bennett K.L., Brena R.M., Jiang J., Claus R., Chen S.-S., et al. Epigenetic modification of CCAAT/enhancer binding protein alpha expression in acute myeloid leukemia. Cancer Res 2008, 68:3142-3151.
39. Kroeger H., Jelinek J., Estécio M.R.H., He R., Kondo K., Chung W., et al. Aberrant CpG island methylation in acute myeloid leukemia is accentuated at relapse. Blood 2008, 112:1366-1373.
40. Melki J.R., Vincent P.C., Clark S.J. Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia. Cancer Res 1999, 59:3730-3740.
41. Figueroa M.E., Lugthart S., Li Y., Erpelinck-Verschueren C., Deng X., Christos P.J., et al. DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia. Cancer Cell 2010, 17:13-27.
42. Fazzari M.J., Greally J.M. Epigenomics: beyond CpG islands. Nat Rev Genet 2004, 5:446-455.
43. Huang Y.-W., Huang T.H.-M., Wang L.-S. Profiling DNA methylomes from microarray to genome-scale sequencing. Technol Cancer Res Treat 2010, 9:107-218.
44. Weng Y.-I., Huang T.H.M., Yan P.S. Methylated DNA immunoprecipitation and microarray-based analysis: detection of DNA methylation in breast cancer cell lines; molecular endocrinology. Methods in molecular biology 2009, 165-176. Humana Press, New York, USA. J.M. Walker (Ed.).
45. Sengenès J., Daunay A., Charles M.-A., Tost J. Quality control and single nucleotide resolution analysis of methylated DNA immunoprecipitation products. Anal Biochem 2010, 407:141-143.
46. Irizarry R.A., Ladd-Acosta C., Wen B., Wu Z., Montano C., Onyango P., et al. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet 2009, 41:178-186.
47. Nair S.S., Coolen M.W., Stirzaker C., Song J.Z., Statham A.L., Strbenac D., et al. Comparison of methyl-DNA immunoprecipitation (MeDIP) and methyl-CpG binding domain (MBD) protein capture for genome-wide DNA methylation analysis reveal CpG sequence coverage bias. Epigenetics 2011, 6:34-44.
48. Saied M.H., Marzec J., Khalid S., Smith P., Down T.A., Rakyan V.K., et al. Genome wide analysis of acute myeloid leukemia reveal leukemia specific methylome and subtype specific hypomethylation of repeats. PLoS ONE 2012, 7.